Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Selexipag

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 203,962Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alembic Gets USFDA Tentative Approval For Selexipag Injection
    Alembic Gets USFDA Tentative Approval For Selexipag Injection

    14 Jul 2024

    // INDIANPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/alembic-announces-usfda-tentative-approval-for-selexipag-for-injection-1800-mcgvial-15871

    INDIANPHARMAPOST
    14 Jul 2024
    Share Share
    Johnson & Johnson 1Q Results
    Johnson & Johnson 1Q Results

    20 May 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2024-05-20/johnson-amp-johnson-1q-results/?widget=listSection

    CONTRACT PHARMA
    20 May 2024
    Share Share
    Cipla`s Generic Selexipag Receives Approval in the U.S.
    Cipla`s Generic Selexipag Receives Approval in the U.S.

    11 Mar 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216607

    FDA
    11 Mar 2024
    Share Share
    Zydus' Generic Selexipag Receives Approval in the U.S.
    Zydus' Generic Selexipag Receives Approval in the U.S.

    21 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214302

    FDA
    21 Dec 2022
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Uptravi (Selexipag)
    FDA Confirms Paragraph IV Patent Litigation for Uptravi (Selexipag)

    22 Sep 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-uptravi-selexipag-37134.pdf

    FDA
    22 Sep 2022
    Share Share
    Zydus receives tentative approval from US FDA for Selexipag tablets
    Zydus receives tentative approval from US FDA for Selexipag tablets

    06 May 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/zydus-receives-tentative-approval-from-us-fda-for-selexipag-tablets/

    EXPRESS PHARMA
    06 May 2022
    Share Share